Remove Heart Attack Remove Reimbursement Remove Research
article thumbnail

Revolutionizing Hypertension Treatment: The Promise of Renal Denervation

Wellnest

This condition poses a heightened risk for cardiovascular events, including heart attacks, strokes, and kidney problems. Latest research in Renal Denervation The Paradise by Recor Medical How does Paradise renal denervation work? Dr. Kirtane echoes concerns about reimbursement, anticipating a potential impediment initially.

article thumbnail

Supercharging the ECG: AI set to Revolutionize the Diagnostic Cardiology Market

DAIC

Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyze and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease. By 1909 ECGs were being used to diagnose cases of arrhythmia; by 1910 to diagnose indicators of a heart attack.

AFIB 105
article thumbnail

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

DAIC

Results showed reductions in heart death equivalents and MACCE, with a magnified reduction among patients with elevated NTproBNP, a common marker of heart distress. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement. vs. 13.2%, respectively).